Literature DB >> 14508162

Impact of myocardial perfusion imaging on clinical management and the utilization of hospital resources in suspected acute coronary syndromes.

B G Abbott1, D Jain.   

Abstract

Recent advances in the treatment of acute coronary syndromes has raised awareness in the community that prompt presentation for chest pain may be life saving. Each year in the United States, more than 6 million people present to the hospital with an acute chest pain, making this the most common presenting chief complaint second only to abdominal pain. Most patients presenting with chest discomfort have a non-ischaemic electrocardiogram on presentation. However, these patients are routinely admitted to hospital due to diagnostic uncertainty for occult myocardial infarction or ischaemia. As an approach to this dilemma, many hospitals have created protocols as a means of facilitating the identification of infarction and ischaemia and the safe and effective triage of patients with a chief complaint of chest pain. Myocardial perfusion imaging at rest has been shown to be highly sensitive for the detection of acute myocardial infarction, and can be supplemented with provocative testing after infarction has been excluded. Diagnostic strategies that utilize myocardial perfusion imaging for the evaluation of acute chest pain have successfully improved the triage of these patients by avoiding inadvertent discharge of patients with myocardial infarctions, and reducing unnecessary hospital admissions and overall cost and expenditure.

Entities:  

Mesh:

Year:  2003        PMID: 14508162     DOI: 10.1097/00006231-200310000-00006

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  2 in total

1.  Myocardial perfusion imaging in a patient with chest pain.

Authors:  Gurusher S Panjrath; Kalyani Narra; Diwakar Jain
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

2.  Detection of chest pain of non-cardiac origin at the emergency room by a new non-invasive device avoiding unnecessary admission to hospital.

Authors:  M Gorenberg; A Marmor; H Rotstein
Journal:  Emerg Med J       Date:  2005-07       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.